Exemplos de uso de Tumour progression em Inglês e suas traduções para o Português
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
Shortened time to tumour progression in patients with advanced head and neck cancer receiving.
There was also a significant advantage of Palladia over placebo in the secondary efficacy endpoint, time to tumour progression.
Survival and tumour progression have been examined in five large controlled studies involving a total ro.
In several controlled studies, epoetins have not been shown to improve overall survival ordecrease the risk of tumour progression in patients with anaemia associated with cancer.
Survival and tumour progression have been examined in five large controlled studies of epoetin alfa.
In several controlled studies, epoetins have not been shown to improve overall survival ordecrease the risk of tumour progression in patients with anaemia associated with cancer.
In case of tumour progression, treatment is unlikely to be successful and should be reviewed.
In several controlled studies, epoetins have not been shown to improve overall survival ordecrease the risk of tumour progression in patients with anaemia associated with cancer.
The role of ESAs on tumour progression or reduced progression-free survival cannot be excluded.
The primary efficacy endpoint of the study was TTP,defined as the time from randomization to first documentation of objective tumour progression.
Survival outcomes and tumour progression in cancer patients that are being treated with Dynepo for anaemia associated with chronic renal failure lp.
Activating mutations in the KRAS gene occur frequently in a variety human tumours andhave been implicated in both oncogenesis and tumour progression.
Survival outcomes and tumour progression in cancer patients that are being treated with Dynepo for anaemia associated with chronic renal failure have not been investigated.
Activating mutations in the RAS genes occur frequently in a varietyof human tumours and have been implicated in both oncogenesis and tumour progression.
Survival and tumour progression have been examined in five large controlled studies involving a total of 2' 833 patients, of which four were double-blind placebo-controlled studies and one was an open- label study.
In several controlled studies, epoetins have not been shown to improve overall survival ordecrease the risk of tumour progression in patients with anaemia associated with cancer.
Hortened time to tumour progression in patients with advanced head and neck cancer receiving radiation therapy when administered to target a haemoglobin of greater than 14 g/dl 8.7 mmol/l.
To further investigate at post-approval the possible change in PD-L1 status of the tumour during treatment and/or tumour progression in Studies CA209-009, CA209-038 and CA209-064.
Hortened time to tumour progression in patients with advanced head and neck cancer receiving radiation therapy when administered to target a haemoglobin of greater than 14 g/dl 8.7 mmol/l.
Increases in AST and ALT or total bilirubin should be evaluated to exclude other causes of hepatic injury,including infections, tumour progression, or concomitant medication and monitored until resolution.
Survival and tumour progression have been examined in five large controlled studies involving a total of 2833 patients, of which four were double-blind placebo-controlled studies and one was an open- label study.
In BRCA-deficient in vivo models,olaparib given after platinum treatment resulted in a delay in tumour progression and an increase in overall survival compared to platinum treatment alone.
Survival and tumour progression have been examined in five large controlled studies involving a total of 2833 patients, of which four were double-blind placebo-controlled studies and one was an open- label study.
Reported studies in leterature indicates that aberrations in signaling pathways similar to those found during tooth development, including wnt1 and gsk3β pathways, apc and axin1 proteins which form the β-catenin degradation complex may be altered in ameloblastoma,leading to proliferation and tumour progression.
Despite decades of cancer research, the early phases of tumour progression that connect the appearance of few abnormal cells to the formation of a clinically detectable tumour mass remains poorly understood.
Survival and tumour progression have been examined in five large controlled studies involving a total of 2,833 patients, of which four were double-blind placebo-controlled studies and one was an open- label study.
Given the evidence for the participation of proteoglycans in tumour progression, this study aimed to assess versican expression and its association with cell surface receptors; human epidermal growth factor receptors 1, 2, and 3(egfr, her-2, and her-3) and cd44 in benign mixed tumours(bmts), carcinomas in mixed tumours(cmts), and carcinosarcomas(css) of the canine mammary gland.
Survival and tumour progression have been examined in five large controlled studies of epoetin alfa, beta and darbepoetin alfa involving a total of 2,833 patients, of which four were double-blind placebo- controlled studies and one was an open-label study.
Efficacy is based on time to tumour progression(TTP) and an increase in survival in GIST, on progression free survival and objective response rates for treatment-naïve and cytokine-refractory MRCC respectively, and on progression free survival for pNET.
We do not know what are the parameters of tumour progression that have been monitored and for how long the patient has been monitored-many potentially beneficial effects of antineoplastic drugs(or of cannabis in this case) are just short-term actions, but what about long-term progression-free survival and overall survival?